Onmedica -- A treatment generally regarded as helpful to a premature baby’s survival by boosting their immune cell count has been shown to be ineffective, according to a study in The Lancet.
Onmedica -- A treatment generally regarded as helpful to a premature baby’s survival by boosting their immune cell count has been shown to be ineffective, according to a study in The Lancet.
